Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)

China flag China · Delayed Price · Currency is CNY
58.37
-1.35 (-2.26%)
Mar 9, 2026, 3:00 PM CST
25.76%
Market Cap 4.90B
Revenue (ttm) 340.38M
Net Income (ttm) -39.71M
Shares Out 83.87M
EPS (ttm) -0.47
PE Ratio n/a
Forward PE n/a
Dividend 6.80 (11.65%)
Ex-Dividend Date Sep 11, 2025
Volume 1,228,288
Average Volume 1,330,915
Open 59.39
Previous Close 59.72
Day's Range 57.19 - 59.50
52-Week Range 38.73 - 94.00
Beta 0.65
RSI 34.34
Earnings Date Apr 23, 2026

About SHA:688399

Jiangsu Bioperfectus Technologies Co., Ltd., a molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. The company offers in vitro diagnostic reagents and supporting testing equipment, as well as in vitro testing services. It also provides HPV and cervical cancer testing services, respiratory infection detection solution, solutions for infectious diarrhea, and STI detection solution for reproductive tract infections. Jiangsu Bioperfectus Technologies Co., Ltd. was founde... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 586
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688399
Full Company Profile

Financial Performance

In 2025, SHA:688399's revenue was 340.38 million, a decrease of -2.64% compared to the previous year's 349.61 million. Losses were -39.71 million, 1883.8% more than in 2024.

Financial Statements

News

There is no news available yet.